The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Nagendran Sukumar

Reporting owner CIK 0001665124 · President and Head of R&D · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Nagendran SukumarNagendran SukumarNagendran Sukumar · December 1, 2025 · Exercise / conversion · Common StockNagendran Sukumar · November 28, 2025 · Exercise / conversion · Common StockNagendran Sukumar · November 28, 2025 · Exercise / conversion · Common StockNov 28, 2025Dec 1, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 1, 2025Taysha Gene Therapies, Inc.Common StockNagendran SukumarExercise / conversion
Nov 28, 2025Taysha Gene Therapies, Inc.Common StockNagendran SukumarExercise / conversion
Nov 28, 2025Taysha Gene Therapies, Inc.Common StockNagendran SukumarExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Taysha Gene Therapies, Inc.TSHA · company listings
Nagendran SukumarPresident and Head of R&D · Director
Exercise / conversionCommon StockNon-derivative security · Code M260,0471.71Value: 444,680.37Currency not specifiedView ↗
Trade: Taysha Gene Therapies, Inc.TSHA · company listings
Nagendran SukumarPresident and Head of R&D · Director
Exercise / conversionCommon StockNon-derivative security · Code M39,9531.71Value: 68,319.63Currency not specifiedView ↗
Trade: Taysha Gene Therapies, Inc.TSHA · company listings
Nagendran SukumarPresident and Head of R&D · Director
Exercise / conversionCommon StockNon-derivative security · Code M70,1720.6989Value: 49,043.2108Currency not specifiedView ↗